ESC Professional Premium Access

Impact of CHA2DS2-VASc score on smartphone-based screening for atrial fibrillation: A pre-specified subgroup analysis of the eBRAVE-AF trial

Congress Presentation

About the speaker

Doctor Luisa Freyer

Ludwig Maximilians University, Munich (Germany)
0 follower

6 more presentations in this session

Factors for incorrect automated atrial fibrillation identification in large-scale screening

Speaker: Doctor M. Zink (Aachen, DE)


Diagnostic accuracy of handheld single-lead electrocardiographic devices to detect atrial fibrillation: an examination using more than 30,000 rhythm traces in a randomised control trial.

Speaker: Doctor K. Wong (Sydney, AU)


A polygenic risk score predicts atrial fibrillation in patients with coronary artery disease without severe systolic dysfunction.

Speaker: Doctor R. Sandhu (Los Angeles, US)


The significance of excessive supraventricular ectopic activity immediately after catheter ablation in the risk stratification for late recurrence of atrial fibrillation

Speaker: Doctor T. Fujisawa (Toon, JP)


Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy

Speaker: Doctor T. Sakthivel (Copenhagen, DK)


Access the full session

Risks and screening for atrial fibrillation

Speakers: Doctor L. Freyer, Doctor M. Zink, Doctor K. Wong, Doctor R. Sandhu, Doctor T. Fujisawa...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by